WillsEye Expert Commentary

• Rubber Bullets, Tear Gas: What Doesn't Kill Can Still Blind   Use of rubber bullets and tear gas during the recent protests has led to significant eye injuries. Dr Ann Murchison offers guidance on appropriate ocular management in the midst of a pandemic.
  Wills Eye Hospital, July 14, 2020
• Skipping Treatment for Diabetic Retinopathy Carries Risks   Drs Jason Hsu and Anthony Obeid on how the 25% of patients lost to follow-up are vulnerable to vision loss and other adverse outcomes.
  Wills Eye Hospital, December 07, 2018
• For Dry Eye, Transnasal Neurostimulator Activates Real Tears   Drs Rapuano and Meghpara describe a unique new device that helps patients with dry eye produce their own tears.
  Wills Eye Hospital, July 26, 2018
• First Artificial Iris Approved   Following the recent approval by the US Food and Drug Administration (FDA) of the first artificial iris, Dr Brandon Ayres describes this groundbreaking solution for patients.
  Wills Eye Hospital, July 10, 2018
• Shingles and Shingles Vaccine: An Update   A recently approved shingles vaccine seems to be more effective in preventing the virus. Drs Rapuano and Meghpara from Wills Eye Hospital discuss its role for patients.
  Wills Eye Hospital, January 05, 2018
• Corneal Crosslinking: What Your Patients Can Expect   Dr Christopher Rapuano discusses the likely outcomes and recovery for this newly approved treatment for keratoconus.
  Wills Eye Hospital, August 21, 2017
• Managing Dry Eye, Step by Step   Dr Christopher Rapuano sorts through the updated recommendations for dry eye provided in the recently published report of the Tear Film & Ocular Surface Society International Dry Eye Workshop II.
  Wills Eye Hospital, August 04, 2017
• A 'Symfony' of Hope for Cataract Patients   From distance and near vision to astigmatism and chromatic aberration, the new Symfony intraocular lens seems to correct it all.
  Wills Eye Hospital, August 12, 2016
• A Game Changer in the Treatment of Dry Eye   Drs Rapuano and Nagra from Wills Eye discuss the recently approved drug lifitegrast (Xiidra), the only one indicated to treat the signs and symptoms of dry eye, and a promising new option for patients.
  Wills Eye Hospital, July 26, 2016
• Corneal Crosslinking: Advancing the Treatment of Keratoconus   Corneal transplantation has been the only curative treatment for progressive keratoconus until now. Drs Rapuano and Feldman discuss a newly approved treatment option that is available.
  Wills Eye Hospital, May 17, 2016